FOLH1 and prostate carcinoma: Kaittanis et al. analyzed genomic data from prostate cancer patients and found that higher PSMA expression was positively related to faster biochemical recurrence (higher PSMA expression was defined as a z-score >2 and low PSMA expression as a z-score ≤ 2) and metastasis [29].